CG
INO icon

Cutler Group’s Inovio Pharmaceuticals INO Stock Holding History

Cutler Group’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-83
Closed -$6K – 4775
2022
Q3 		$6K Hold
83
– – ﹤0.01% 3505
2022
Q2 		$6K Hold
83
– – ﹤0.01% 3583
2022
Q1 		$4K Sell
83
-4,434
-98% -$200K ﹤0.01% 4278
2021
Q4 		$206K Buy
4,517
+4,167
+1,191% +$334K 0.01% 1290
2021
Q3 		$139K Hold
350
– – 0.01% 1641
2021
Q2 		$134K Buy
350
+83
+31% +$7.97K 0.01% 1623
2021
Q1 		$133K Sell
267
-33
-11% -$4.34K 0.01% 1552
2020
Q4 		$141K Sell
300
-1,075
-78% -$143K 0.01% 1296
2020
Q3 		$181K Sell
1,375
-1,458
-51% -$304K 0.01% 969
2020
Q2 		$122K Sell
2,833
-3,050
-52% -$490K 0.01% 1174
2020
Q1 		$155K Buy
+5,883
New +$363K 0.01% 1099
2017
Q4 		– Sell
-342
Closed -$1K – 5355
2017
Q3 		$1K Sell
342
-808
-70% -$60.1K ﹤0.01% 5440
2017
Q2 		$7K Sell
1,150
-158
-12% -$13.5K ﹤0.01% 4522
2017
Q1 		$13K Sell
1,308
-42
-3% -$3.35K ﹤0.01% 3785
2016
Q4 		$11K Sell
1,350
-267
-17% -$24.1K ﹤0.01% 4092
2016
Q3 		$12K Buy
1,617
+159
+11% +$17.6K ﹤0.01% 4000
2016
Q2 		$18K Buy
1,458
+250
+21% +$30.4K ﹤0.01% 3480
2016
Q1 		$12K Buy
1,208
+400
+50% +$30.9K ﹤0.01% 3848
2015
Q4 		$38K Buy
+808
New +$64.3K ﹤0.01% 2756

Other funds holding INO

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cutler Group's INO Position: Q1 2023 in Review

Cutler Group sold out of Inovio Pharmaceuticals (INO) in Q1 2023, closing a stake of 58 shares — an estimated $1K sold.

Cutler Group first reported a position in INO in Q4 2015 and held it in 21 quarters. The position peaked at $189K in Q4 2021. 174 funds tracked by Wall St. Rank hold INO as of Q1 2023.

  • Cutler Group reported no remaining Inovio Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • Cutler Group sold 58 Inovio Pharmaceuticals shares in Q1 2023, an estimated $1K.
  • Cutler Group first reported a position in Inovio Pharmaceuticals in Q4 2015 and held it in 21 quarters.
  • Cutler Group's Inovio Pharmaceuticals position peaked at $189K in Q4 2021.
  • 174 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q1 2023.

Based on Cutler Group's 13F filing for Q1 2023, filed 1 May 2023.